08/25/2025
3:29 PM | Coastlands Capital LP (Filed by)
Whitehawk Therapeutics, Inc. (Subject)
Whitehawk Therapeutics (Subject)
| Form SCHEDULE 13G | |
08/07/2025
7:03 AM | Whitehawk Therapeutics, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2025
7:10 PM | Whitehawk Therapeutics, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Zhao Baiteng (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
5:46 PM | ORBIMED ADVISORS LLC (Filed by)
Whitehawk Therapeutics, Inc. (Subject)
Whitehawk Therapeutics (Subject)
| Form SCHEDULE 13G | |
05/08/2025
4:28 PM | Whitehawk Therapeutics, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/28/2025
3:49 PM | Whitehawk Therapeutics, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form ARS | |
04/28/2025
3:32 PM | Whitehawk Therapeutics, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form DEF 14A | |
04/28/2025
3:34 PM | Whitehawk Therapeutics, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025
3:50 PM | Whitehawk Therapeutics, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form 424B5 | |
04/08/2025
11:15 PM | Whitehawk Therapeutics, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form EFFECT | |
04/03/2025
6:22 PM | Lennon David James (Reporting)
Whitehawk Therapeutics, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for WHWK and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Whitehawk Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/03/2025
6:23 PM | Giacobello Scott M. (Reporting)
Whitehawk Therapeutics, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
6:24 PM | BALL BRYAN (Reporting)
Whitehawk Therapeutics, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/31/2025
4:29 PM | Whitehawk Therapeutics, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/31/2025
3:57 PM | Whitehawk Therapeutics, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form 8-K/A | |
03/28/2025
3:53 PM | Whitehawk Therapeutics, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/26/2025
7:21 AM | Whitehawk Therapeutics, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
3:38 PM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2025
8:29 AM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/11/2025
6:22 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SCHEDULE 13G | |
03/10/2025
3:30 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
ABG Management Ltd. (Filed by)
| Form SCHEDULE 13G | |
03/06/2025
4:55 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
Desai Neil (Filed by)
| Form SCHEDULE 13D/A | |
03/05/2025
6:51 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Dalal Anupam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
2:58 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
03/04/2025
6:24 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Castelein Caley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:09 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
BALL BRYAN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:11 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Dornan David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
5:14 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Zhao Baiteng (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:56 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Aghazadeh Behzad (Reporting)
Avoro Capital Advisors LLC (Reporting)
Avoro Ventures LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2025
4:58 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SCHEDULE 13D/A | |
03/03/2025
7:34 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
Giacobello Scott M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
7:36 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
Lennon David James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/03/2025
7:37 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Lennon David James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:38 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Giacobello Scott M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
7:31 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
BALL BRYAN (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
10:38 AM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
02/19/2025
4:08 PM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form DEFA14A | |
02/14/2025
1:00 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
QVT Financial LP (Filed by)
| Form SCHEDULE 13G | |
02/14/2025
11:11 AM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/04/2025
10:11 AM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
01/31/2025
4:09 PM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form DEFM14A | |
Capital Gains Tax Strategies for Seniors (Ad) Capital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holding investments longer to using tax-advantaged accounts and strategic loss offsetting, there are ways to reduce your exposure.
SmartAsset outlines three capital gains tax strategies for seniors and offers a free tool to connect you with vetted fiduciary financial advisors who can help tailor these tactics to your situation. Click here to see the three strategies and get matched with a financial advisor today. |
01/30/2025
2:32 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D | |
01/29/2025
6:01 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SCHEDULE 13G | |
01/24/2025
1:34 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
ACUTA CAPITAL PARTNERS, LLC (Filed by)
| Form SCHEDULE 13D/A | |
01/21/2025
3:54 PM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form PREM14A | |
12/31/2024
10:13 AM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SCHEDULE 13D | |
12/30/2024
4:04 PM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form DEFA14A | |
12/23/2024
4:34 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Zhao Baiteng (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/23/2024
4:36 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Zhao Baiteng (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
4:26 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
Desai Neil (Filed by)
| Form SCHEDULE 13D/A | |
12/23/2024
2:51 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SCHEDULE 13D/A | |
12/20/2024
5:05 AM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
5:08 AM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form DEFA14A | |
11/06/2024
3:08 PM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
7:05 AM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
6:01 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
Lennon David James (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
6:03 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Lennon David James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
4:35 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
Desai Neil (Filed by)
| Form SC 13D/A | |
09/30/2024
5:06 AM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:13 PM | Aadi Bioscience, Inc. (Filer)
Whitehawk Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
4:55 PM | Aadi Bioscience, Inc. (Issuer)
Whitehawk Therapeutics (Issuer)
Desai Neil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
4:51 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G | |
09/03/2024
9:40 AM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
Desai Neil (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:42 PM | Aadi Bioscience, Inc. (Subject)
Whitehawk Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
MarketBeat All Access